DailyDoctor Archive Specialties Get app
Back to the 25 October 2026 edition

Clinical update · 01 of 05

Survivorship care during radiotherapy linked to better adherence and survival

Worth bringing multidisciplinary survivorship support forward into the radiotherapy course for head and neck cancer.

Design
Retrospective single-centre cohort
Population
471 patients with head and neck cancer completing definitive radiotherapy, 2018–2025
Primary outcome
Radiotherapy adherence, 3-year recurrence and disease-free survival
Effect
Non-adherence OR 0.45 (0.27–0.75); DFS HR 0.61 (0.41–0.91)

This retrospective cohort included 471 patients with head and neck cancer completing curative-intent radiotherapy at one US academic centre between 2018 and 2025. Of these, 148 (31%) attended a multidisciplinary survivorship clinic before radiotherapy ended.

After adjustment for clinical and social factors, attendees had lower odds of radiotherapy non-adherence (OR 0.45, 95% CI 0.27–0.75), a lower three-year recurrence risk (SHR 0.62, 0.40–0.94) and better three-year disease-free survival (HR 0.61, 0.41–0.91).

This is observational: patients who attend an extra clinic during treatment may differ in motivation and support in ways that adjustment cannot capture. But the mechanism is plausible — managing swallowing, nutrition, pain and distress during radiotherapy keeps people on treatment — and those supports cost little to bring forward.

  • Consider starting survivorship support — swallowing, nutrition, pain, mood — during radiotherapy rather than after it.
  • Flag patients at risk of interrupting radiotherapy early and involve dietetics and speech therapy.
  • Treatment gaps in head and neck radiotherapy are worth tracking as a service measure.
  • Interpret the survival benefit cautiously; the study shows an association.

Why it matters

It suggests survivorship care may be part of treatment, not only what comes after it.

Don't overread it

Observational and single-centre; attendance was not randomised.

The statistics, in plain English

An odds ratio of 0.45 means less than half the odds of non-adherence. A hazard ratio of 0.61 for disease-free survival means about 39% lower rate of recurrence or death over follow-up — but in a non-randomised comparison, healthier or better-supported patients may simply be more likely to attend.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

headneckoncpaedentsleepairwayotology

Tomorrow morning, before your first patient

One edition a day for ent & head and neck surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app